SCHEMBL6100663

SCHEMBL6100663

O=C1c2c(c(O)c3nccnc3c2O)C(=O)N1CC1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 3/20 0.39
BRD4 O60885 1/20 0.37
TRPA1 O75762 2/20 0.37
P4HB P07237 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP19A1 P11511 2/20 0.36
TGM2 P21980 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP2B6 P20813 1/20 0.34
PDE1A P54750 2/20 0.34
PDE1B Q01064 2/20 0.34
PDE1C Q14123 2/20 0.34
KDM4C Q9H3R0 1/20 0.34
MTOR P42345 1/20 0.33
FEN1 P39748 1/20 0.33
CYP11B2 P19099 1/20 0.33
BACE1 P56817 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6098819 0.75 CYP19A1 (0.44) CYP19A1KDM4EALDH1A1
SCHEMBL6101777 0.75 ALDH1A1 (0.44) KMT2AKDM4EALDH1A1NPSR1HSD17B10
SCHEMBL6099563 0.72 KDM4E (0.45) KMT2ACYP19A1KDM4EALDH1A1
SCHEMBL13943750 0.70 BRD4 (0.32) CYP1B1BRD4CYP19A1KDM4EALDH1A1
SCHEMBL6099694 0.67 CYP1B1 (0.41) CYP1B1KMT2AKDM4EALDH1A1FEN1
SCHEMBL3379777 0.67 MTOR (0.42) CYP1B1BRD4TRPA1P4HBKMT2A
SCHEMBL8315308 0.67 CYP1B1 (0.48) CYP1B1TRPA1CYP19A1
SCHEMBL30657539 0.66 CYP1B1 (0.62) CYP1B1TRPA1ALDH1A1NPSR1HSD17B10
SCHEMBL8247166 0.66 CYP1B1 (0.62) CYP1B1TRPA1ALDH1A1NPSR1HSD17B10
SCHEMBL5766281 0.66 PARP1 (0.36) KMT2AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060211724-A1 Hiv integrase inhibitors VERSCHUEREN GASTON W 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211724-A1 Hiv integrase inhibitors SULT1A1, SULT2A1, SULT1E1 CYP1B1 23/4885BRD4 4056/4885TRPA1 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.